Rapport Therapeutics Income Statement (2023-2026) | RAPP

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 20.00M
Operating items
Research & Development (Quarter) 4.72M7.58M11.80M12.50M15.69M15.54M17.20M19.57M22.68M22.28M30.26M32.72M
Selling, General & Administrative (Quarter) 1.91M1.98M3.00M4.59M5.11M6.10M6.32M7.54M6.82M7.71M8.25M11.50M
Operating Expenses (Quarter) 6.63M9.56M14.79M17.09M20.80M21.64M23.52M27.11M29.50M29.99M38.51M44.22M
Operating Income (Quarter) -6.63M-9.56M-14.79M-17.09M-20.80M-21.64M-23.52M-27.11M-29.50M-29.99M-38.51M-24.21M
EBIT (Quarter) -6.63M-9.56M-14.79M-17.09M-20.80M-21.64M-23.52M-27.11M-29.50M-29.99M-38.51M-24.21M
Non-operating items
Interest & Investment Income (Quarter) 0.22M0.86M1.38M1.81M2.68M4.10M3.54M3.04M2.76M3.06M4.75M4.36M
Non Operating Income (Quarter) 0.22M0.86M1.28M-5.58M2.68M4.10M3.54M3.04M2.76M3.06M4.75M4.36M
Net income details
EBT (Quarter) -6.41M-8.71M-13.51M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Tax Provisions (Quarter) 0.00M0.00M0.01M
Profit After Tax (Quarter) -6.41M-8.71M-13.53M-22.67M-18.12M-17.54M-19.97M-24.06M-26.73M-26.93M-33.78M-19.86M
Income from Continuing Operations (Quarter) -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Consolidated Net Income (Quarter) -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Income towards Parent Company (Quarter) -6.41M-8.71M-13.52M-15.28M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Net Income towards Common Stockholders (Quarter) -6.41M-8.71M-13.52M-22.67M-18.12M-17.54M-19.98M-24.06M-26.73M-26.93M-33.76M-19.86M
Additional items
EPS (Basic) (Quarter) -4.45-5.70-8.38-11.07-1.70-0.50-0.12-0.68-0.75-0.71-0.71-0.42
EPS (Weighted Average and Diluted) (Quarter) -4.45-5.70-8.38-11.07-1.70-0.50-0.12-0.68-0.75-0.71-0.71-0.42
Shares Outstanding (Weighted Average) (Quarter) 1.40M1.44M1.51M2.05M10.67M34.86M20.74M35.27M35.36M37.93M38.93M47.24M
Shares Outstanding (Diluted Average) (Quarter) 1.40M1.44M1.51M2.05M10.67M15.93M20.74M35.27M35.44M37.93M38.93M47.24M
EBITDA (Quarter) -6.41M-8.71M-13.52M-22.83M-18.14M-16.95M-20.90M-23.64M-26.71M-26.70M-33.36M-20.91M
Shares Outstanding (Quarter) 4.22M4.17M4.17M4.17M36.58M36.58M36.58M36.50M36.50M47.65M47.77M47.81M
Tax Rate (Quarter) -0.03-0.01-0.04